2008 JASN IMPACT FACTOR 7.505	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ziyadeh, F. N. Search for Related Content PubMed PubMed Citation Articles by Ziyadeh, F. N.

Mediators of Diabetic Renal Disease: The Case for TGF- as the Major Mediator

Penn Center for Molecular Studies of Kidney Diseases, Renal-Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

Correspondence to Dr. Fuad N. Ziyadeh, Renal-Electrolyte and Hypertension Division, University of Pennsylvania, 700 Clinical Research Building, 415 Curie Boulevard, Philadelphia, PA 19104-4218. Phone: 215-573-1837; Fax: 215-898-0189; E-mail: ziyadeh{at}mail.med.upenn.edu

ABSTRACT. The critical role of hyperglycemia in the genesis of diabetic nephropathy has been established by cell culture studies, experimental animal models, and clinical trials. Certain cytokines and growth factors have been identified as likely mediators of the effects of high ambient glucose on the kidney, but prominent among these is TGF-, a prototypical hypertrophic and fibrogenic cytokine. Overexpression of TGF- has been demonstrated in the glomerular and tubulointerstitial compartments of experimental diabetic animals. The TGF- receptor signaling system is also triggered, as evidenced by upregulation of the TGF- type II receptor and activation of the downstream Smad signaling pathway. Treatment of diabetic mice with neutralizing anti–TGF- antibodies prevents the development of renal hypertrophy, mesangial matrix expansion, and the decline in renal function. Antibody therapy also reverses the established lesions of diabetic glomerulopathy. These studies argue strongly in support of the hypothesis that overactivity of the TGF- system in the kidney is a crucial mediator of diabetic renal hypertrophy and mesangial matrix expansion.

This article has been cited by other articles:

				J. Wu, C. Mei, H. Vlassara, G. E. Striker, and F. Zheng Oxidative stress-induced JNK activation contributes to proinflammatory phenotype of aging diabetic mesangial cells Am J Physiol Renal Physiol, December 1, 2009; 297(6): F1622 - F1631. [Abstract] [Full Text] [PDF]

				B. L. Riser, F. Najmabadi, B. Perbal, D. R. Peterson, J. A. Rambow, M. L. Riser, E. Sukowski, H. Yeger, and S. C. Riser CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal Disease Am. J. Pathol., May 1, 2009; 174(5): 1725 - 1734. [Abstract] [Full Text] [PDF]

				N. Herbach, I. Schairer, A. Blutke, S. Kautz, A. Siebert, B. Goke, E. Wolf, and R. Wanke Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis Am J Physiol Renal Physiol, April 1, 2009; 296(4): F819 - F829. [Abstract] [Full Text] [PDF]

				D. Wu, F. Peng, B. Zhang, A. J. Ingram, D. J. Kelly, R. E. Gilbert, B. Gao, and J. C. Krepinsky PKC-{beta}1 Mediates Glucose-Induced Akt Activation and TGF-{beta}1 Upregulation in Mesangial Cells J. Am. Soc. Nephrol., March 1, 2009; 20(3): 554 - 566. [Abstract] [Full Text] [PDF]

				C. E. Hills, N. Al-Rasheed, N. Al-Rasheed, G. B. Willars, and N. J. Brunskill C-peptide reverses TGF-{beta}1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy Am J Physiol Renal Physiol, March 1, 2009; 296(3): F614 - F621. [Abstract] [Full Text] [PDF]

				J. H. Garman, S. Mulroney, M. Manigrasso, E. Flynn, and C. Maric Omega-3 fatty acid rich diet prevents diabetic renal disease Am J Physiol Renal Physiol, February 1, 2009; 296(2): F306 - F316. [Abstract] [Full Text] [PDF]

				I. F. Tsigelny, V. L. Kouznetsova, D. E. Sweeney, W. Wu, K. T. Bush, and S. K. Nigam Analysis of Metagene Portraits Reveals Distinct Transitions During Kidney Organogenesis Sci. Signal., December 9, 2008; 1(49): ra16 - ra16. [Abstract] [Full Text] [PDF]

				L. Xia, H. Wang, S. Munk, J. Kwan, H. J. Goldberg, I. G. Fantus, and C. I. Whiteside High glucose activates PKC-{zeta} and NADPH oxidase through autocrine TGF-{beta}1 signaling in mesangial cells Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1705 - F1714. [Abstract] [Full Text] [PDF]

				X. Shi, H. Qu, M. Kretzler, and C. Wu Roles of PINCH-2 in regulation of glomerular cell shape change and fibronectin matrix deposition Am J Physiol Renal Physiol, July 1, 2008; 295(1): F253 - F263. [Abstract] [Full Text] [PDF]

				R. E. Pyeritz A Small Molecule for a Large Disease N. Engl. J. Med., June 26, 2008; 358(26): 2829 - 2831. [Full Text] [PDF]

				P. Vieitez, O. Gomez, E. R Uceda, M. E. Vera, and E. Molina-Holgado Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy Journal of Renin-Angiotensin-Aldosterone System, June 1, 2008; 9(2): 96 - 102. [Abstract] [PDF]

				Y. S. Kanwar, J. Wada, L. Sun, P. Xie, E. I. Wallner, S. Chen, S. Chugh, and F. R. Danesh Diabetic Nephropathy: Mechanisms of Renal Disease Progression Experimental Biology and Medicine, January 1, 2008; 233(1): 4 - 11. [Abstract] [Full Text] [PDF]

				P. Kumpers, F. Gueler, S. Rong, M. Mengel, I. Tossidou, I. Peters, H. Haller, and M. Schiffer Leptin is a coactivator of TGF-beta in unilateral ureteral obstructive kidney disease Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1355 - F1362. [Abstract] [Full Text] [PDF]

				M. Andratsch, E. Feifel, L. Taylor, M. O'Hayre, H. Schramek, N. P. Curthoys, and G. Gstraunthaler TGF-beta signaling and its effect on glutaminase expression in LLC-PK1-FBPase+ cells Am J Physiol Renal Physiol, September 1, 2007; 293(3): F846 - F853. [Abstract] [Full Text] [PDF]

				S. P. R. Rao, R. Wassell, M. A. Shaw, and K. Sharma Profiling of human mesangial cell subproteomes reveals a role for calmodulin in glucose uptake Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1182 - F1189. [Abstract] [Full Text] [PDF]

				W. Zhang, H. Meng, Z.-H. Li, Z. Shu, X. Ma, and B.-X. Zhang Regulation of STIM1, store-operated Ca2+ influx, and nitric oxide generation by retinoic acid in rat mesangial cells Am J Physiol Renal Physiol, March 1, 2007; 292(3): F1054 - F1064. [Abstract] [Full Text] [PDF]

				K. Y. Jung, K. Chen, M. Kretzler, and C. Wu TGF-beta1 Regulates the PINCH-1-Integrin-Linked Kinase-{alpha}-Parvin Complex in Glomerular Cells J. Am. Soc. Nephrol., January 1, 2007; 18(1): 66 - 73. [Abstract] [Full Text] [PDF]

				J. M. Sasser, J. C. Sullivan, J. L. Hobbs, T. Yamamoto, D. M. Pollock, P. K. Carmines, and J. S. Pollock Endothelin A Receptor Blockade Reduces Diabetic Renal Injury via an Anti-Inflammatory Mechanism J. Am. Soc. Nephrol., January 1, 2007; 18(1): 143 - 154. [Abstract] [Full Text] [PDF]

				R. Nasrallah, H. Xiong, and R. L. Hebert Renal prostaglandin E2 receptor (EP) expression profile is altered in streptozotocin and B6-Ins2Akita type I diabetic mice Am J Physiol Renal Physiol, January 1, 2007; 292(1): F278 - F284. [Abstract] [Full Text] [PDF]

				E. Bertrand, C. Fritsch, S. Diether, G. Lambrou, D. Muller, F. Schaeffel, P. Schindler, K. L. Schmid, J. van Oostrum, and H. Voshol Identification of Apolipoprotein A-I as a "STOP" Signal for Myopia Mol. Cell. Proteomics, November 1, 2006; 5(11): 2158 - 2166. [Abstract] [Full Text] [PDF]

				I. Sinuani, Z. Averbukh, I. Gitelman, M. J. Rapoport, J. Sandbank, M. Albeck, B. Sredni, and J. Weissgarten Mesangial cells initiate compensatory renal tubular hypertrophy via IL-10-induced TGF-beta secretion: effect of the immunomodulator AS101 on this process Am J Physiol Renal Physiol, August 1, 2006; 291(2): F384 - F394. [Abstract] [Full Text] [PDF]

				B. Nayak, P. Xie, S. Akagi, Q. Yang, L. Sun, J. Wada, A. Thakur, F. R. Danesh, S. S. Chugh, and Y. S. Kanwar Modulation of renal-specific oxidoreductase/myo-inositol oxygenase by high-glucose ambience PNAS, December 13, 2005; 102(50): 17952 - 17957. [Abstract] [Full Text] [PDF]

				J. M. Bohlender, S. Franke, G. Stein, and G. Wolf Advanced glycation end products and the kidney Am J Physiol Renal Physiol, October 1, 2005; 289(4): F645 - F659. [Abstract] [Full Text] [PDF]

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673